$69.15-1.39 (-1.97%)
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America.
Ingevity Corporation in the Basic Materials sector is trading at $69.15 with a market capitalization of $2.4B. Wall Street consensus targets $89.00 (3 analysts), implying a +28.7% move over the next 12 months. The stock is currently 13% below its 52-week high of $79.29, remaining 0.6% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $314.10Mβ | $258.00Mβ | $255.10Mβ | $333.10Mβ | $331.50M |
| Gross Profit | $139.00Mβ | $116.40Mβ | $87.80Mβ | $133.90Mβ | $127.80M |
| Operating Income | $93.90Mβ | $69.00Mβ | $38.80Mβ | $82.80Mβ | $77.20M |
| Net Income | $35.30Mβ | $59.80Mβ | -$84.60Mβ | $43.50Mβ | -$146.50M |
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments:...

NGVT's 19.2% YTD rally is backed by portfolio optimization, stronger hybrid demand, pricing gains and higher margins, fueling earnings growth.

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NGVT's raised 2026 outlook, portfolio transformation and new growth platforms support its momentum and higher-return investment focus.
Hybrid vehicle demand drove margin expansion across all segments.
Here is how Innospec (IOSP) and Ingevity (NGVT) have performed compared to their sector so far this year.